FDA Investigator: Karen C. Daugherty
- Karen C. Daugherty first started conducting FDA inspections in 2000, with the last inspection in 2019. Over that time, Karen C. Daugherty has conducted 188 inspections at 134 companies across 144 sites.
Get Karen Daugherty's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Eric J. Lawitz, M.D., Clinical Investigator, San Antonio | 2010
Out-of-stock
Karen C. Daugherty
Human Drug Form 483
FDA 483 David C. Carter, MD, Austin | 2010
Out-of-stock
Karen C. Daugherty
Human Drug Form 483
FDA 483 Chemische Fabrik Kreussler & Co. Gmbh, Wiesbaden | 2009
Out-of-stock
Karen C. Daugherty
Human Drug Form 483
FDA 483 Sherwyn L Schwartz, M.D., San Antonio | 2009
Out-of-stock
Karen C. Daugherty
Human Drug Form 483
FDA 483 Sovereign Pharmaceuticals, LLC, Fort Worth | 2009
Out-of-stock
Karen C. Daugherty
Human Drug Form 483
FDA 483 CBI Laboratories, Inc., Fort Worth | 2009
Out-of-stock
Karen C. Daugherty
Human Drug Form 483
Co-Investigators (26)
- Christopher J. Hurst, FDA Investigator
- Dana M. Lewis, FDA Investigator
- Tricia S. Martinez, FDA Investigator
- Randy L. Self, FDA Investigator
- Young M. Yoon, FDA Investigator
- Roy Baby, FDA Compliance Officer
- Torrance J. Slayton, FDA Investigator
- Darla J. Christopher, FDA Investigator
- Carla A. Norris, FDA Investigator
- Maria A. Reed, FDA Investigator
- Philip M. Steele, FDA Investigator
- Rebecca C. O Bryan, FDA Investigator
- O Bryan, Rebecca C, FDA Investigator
- Maira P. Brading, FDA Investigator
- Erika V. Butler, FDA Investigator
- Patrick L. Wisor, FDA Investigator
- Kathleen B. Swat, FDA Investigator
- Shirley J. Berryman, FDA Investigator
- James I. Giefer, FDA Investigator
- Nancy P. Hamburg, FDA Investigator
- Megan M. Jekel, FDA Investigator
- David K. Glasgow, FDA Investigator
- Georgia A. Layloff, FDA Investigator
- John A. Iwen, FDA Investigator
- Gwyn G. Dickinson, FDA Investigator
- Robert J. Nesselhauf, FDA Investigator